| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/06/2006 | WO2006046123A3 Conjugates with anti-inflammatory activity |
| 07/06/2006 | WO2006018727A3 Triazolopyridine compounds useful for the treatment of inflammation |
| 07/06/2006 | WO2005116002A3 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/06/2006 | US20060149039 Pseudo-native chemical ligation |
| 07/06/2006 | US20060148907 Topical antinflammatory preparations of y-terpinene |
| 07/06/2006 | US20060148900 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 07/06/2006 | US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 07/06/2006 | US20060148839 New pharmaceutical compositions based on anticholinergics and tace-inhibitors |
| 07/06/2006 | US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase |
| 07/06/2006 | US20060148819 Chemical compounds |
| 07/06/2006 | US20060148798 Antiinflammatory agents; cardiovascular disorders; antidiabetic agents;central nervous system diosrders ; anticancer agents |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148769 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 07/06/2006 | US20060148760 Method for the sysnthesis of compounds of formula I and their uses thereof |
| 07/06/2006 | US20060148751 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 07/06/2006 | US20060148745 DNA-based aptamers for human cathepsin G |
| 07/06/2006 | US20060148732 Inhibition of NF-kappaB by triterpene compositions |
| 07/06/2006 | US20060148707 Use of ligands to GABA beta receptors |
| 07/06/2006 | US20060148689 A peptide consisting of a sequence comprising a tripeptide and tetrapeptide linked or existing separately with specific recognition of lipid vectors, particularly negativelycharged phosphatides on cell surfaces; stability; labels;fluorescence; imaging contrast agents; kitsanalyzing; diagnosis/medical |
| 07/06/2006 | US20060148682 Identifying substrate of an enzyme that is secreted by MCF7/6, HepG2, or HT29 cells; covalently attaching by amidation or esterification the substrate to drug to form a prospective tumor-activated prodrug; drug screening and testing; antitumor, antiinflammatory and anticarcinogenic agents; diagnosis |
| 07/06/2006 | US20060148679 Glycosolated enkephalin agents |
| 07/06/2006 | US20060148035 Host cells containing mannosidase catalytic domains within endoplasmic reticulum or Golgi complex for producing glycoproteins with glycan structures attached in glycoform that serve as substrate for transferases |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147920 Method of judging inflammatory disease |
| 07/06/2006 | US20060147548 Therapeutic delivery of carbon monoxide |
| 07/06/2006 | US20060147510 Method for treating non-neuropathic pain |
| 07/06/2006 | US20060147496 Diagnosis of irritable bowel disorders; fibromyalgia; chronic fatique syndrome; antidepressants; tinnitus; autism; autoimmune disease; Crohn's disease; quantitative analysis of serotonine, bile acid in sample |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147446 Humanized antibodies to human GP39, compositions, and therapeutic uses thereof |
| 07/06/2006 | US20060146644 System for producing micro-cluster liquids |
| 07/06/2006 | DE102004063227A1 Tricylische Aminoalkohole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tri-cyclic amino alcohols, processes for their preparation and their use as anti-inflammatories |
| 07/06/2006 | DE102004027856A1 Neue Pflanzenextrakte mit neuropotektiven, neuroregenerativen und entzündungshemmenden Eigenschaften New plant extracts with neuropotektiven, neuro-regenerative and anti-inflammatory properties |
| 07/06/2006 | CA2594325A1 Condensed imidazole compound and use thereof |
| 07/06/2006 | CA2593862A1 Nanoparticle composition and methods for synthesis thereof |
| 07/06/2006 | CA2591912A1 Pyrimidinylisoxazole derivatives |
| 07/06/2006 | CA2591845A1 Method of reducing oral tissue inflammation using magnolia extract |
| 07/06/2006 | CA2590961A1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 07/06/2006 | CA2590681A1 N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid cb1 receptor antagonists |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676846A2 Hydantoin derivatives as MMP inhibitors |
| 07/05/2006 | EP1676845A1 New quinazoline derivatives |
| 07/05/2006 | EP1676843A1 Substituted indole ligands for the ORL-1 receptor |
| 07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1676575A2 Mucin production inhibitor |
| 07/05/2006 | EP1675854A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 07/05/2006 | EP1675853A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1418881A4 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 07/05/2006 | EP1389044A4 Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| 07/05/2006 | EP1235900B1 Microparticle-based transfection and activation of dendritic cells |
| 07/05/2006 | EP1113797A4 Treatment of persistent pain |
| 07/05/2006 | EP1106175B1 Anti-inflammatory ascorbic acid derivatives |
| 07/05/2006 | EP1105485B1 Human il-1 epsilon dna and polypeptides |
| 07/05/2006 | EP1027038B1 Taste masked pharmaceutical compositions |
| 07/05/2006 | EP0879289B1 Human dnase resistant to actin inhibition |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/05/2006 | CN1798571A Pam的用途 Pam uses |
| 07/05/2006 | CN1798559A Quinoline-2-one-derivatives for the treatment of airways diseases |
| 07/05/2006 | CN1796412A New 0 - ultra family conantokins, coded polynucleotide and application |
| 07/05/2006 | CN1796400A Extractive of phytosterol extracted from bamboo shoot, preparation method and application |
| 07/05/2006 | CN1795903A Black plaster for arthralgia pain |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262296C Medicine composition, preparing method and use for preparing gynecological medicine |
| 07/05/2006 | CN1262292C Medicine composition, preparing method and use for preparing gynecological medicine |
| 07/04/2006 | US7071355 Enzyme inhibitors; anticancer agents; autoimmune diseases; antiprotozoa agents; viricides |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 07/04/2006 | US7071299 For therapy of conditions characterized by inappropriate complement activation; for therapy of adult respiratory distress syndrome, ischemia-reperfusion injury, hyperacute rejection (transplantation), sepsis, cardiopulmonary bypass |
| 07/04/2006 | US7071222 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 07/04/2006 | US7071217 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071196 Piperazine derivatives as antagonists of tachykinins, including substance P and other neurokinins. |
| 07/04/2006 | US7071193 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 07/04/2006 | US7071187 Naphthyridine derivatives |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 07/04/2006 | US7071160 Integrin binding polipeptide for diagnosis, prevention and treatment of renal failure, thrombosis, osteoporosis, cancers and diabetes |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
| 07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
| 07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
| 07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
| 07/04/2006 | CA2462452C Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 06/29/2006 | WO2006069293A2 Composition comprising n-acetylcysteine and further pain or anti- inflamm medications |
| 06/29/2006 | WO2006069258A1 Substituted heterocyclic compounds and methods of use |
| 06/29/2006 | WO2006069210A2 Oral care compositions containing free-b-ring flavonoids and flavans |
| 06/29/2006 | WO2006068760A2 Anti-inflammatory pyrazolopyrimidines |